6.
Corwin P, Toop L, McGeoch G, Than M, Wynn-Thomas S, Wells J
. Randomised controlled trial of intravenous antibiotic treatment for cellulitis at home compared with hospital. BMJ. 2004; 330(7483):129.
PMC: 544431.
DOI: 10.1136/bmj.38309.447975.EB.
View
7.
Cosgrove S, Sakoulas G, Perencevich E, Schwaber M, Karchmer A, Carmeli Y
. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis. 2002; 36(1):53-9.
DOI: 10.1086/345476.
View
8.
Dalovisio J, Juneau J, Baumgarten K, Kateiva J
. Financial impact of a home intravenous antibiotic program on a medicare managed care program. Clin Infect Dis. 2000; 30(4):639-42.
DOI: 10.1086/313755.
View
9.
Esposito S, Noviello S, Leone S, Tice A, Seibold G, Nathwani D
. Outpatient parenteral antibiotic therapy (OPAT) in different countries: a comparison. Int J Antimicrob Agents. 2004; 24(5):473-8.
DOI: 10.1016/j.ijantimicag.2004.06.004.
View
10.
Fowler Jr V, Sanders L, Sexton D, Kong L, Marr K, Gopal A
. Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients. Clin Infect Dis. 1998; 27(3):478-86.
DOI: 10.1086/514686.
View
11.
Gemmell C, Edwards D, Fraise A, Gould F, Ridgway G, Warren R
. Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK. J Antimicrob Chemother. 2006; 57(4):589-608.
DOI: 10.1093/jac/dkl017.
View
12.
Habib G, Lancellotti P, Antunes M, Bongiorni M, Casalta J, Del Zotti F
. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the.... Eur Heart J. 2015; 36(44):3075-3128.
DOI: 10.1093/eurheartj/ehv319.
View
13.
Hoverman I, Gentry L, Jones D, Guerriero W
. Intrarenal abscess. Report of 14 cases. Arch Intern Med. 1980; 140(7):914-6.
DOI: 10.1001/archinte.140.7.914.
View
14.
Jakab F, Egri G, FALLER J
. [Clinical aspects and management of a retroperitoneal abscess]. Orv Hetil. 1992; 133(37):2335-9.
View
15.
Kawashima A, Sandler C, Goldman S, Raval B, Fishman E
. CT of renal inflammatory disease. Radiographics. 1997; 17(4):851-66; discussion 867-8.
DOI: 10.1148/radiographics.17.4.9225387.
View
16.
Kayley J, Berendt A, Snelling M, Moore H, HAMILTON H, Peto T
. Safe intravenous antibiotic therapy at home: experience of a UK based programme. J Antimicrob Chemother. 1996; 37(5):1023-9.
DOI: 10.1093/jac/37.5.1023.
View
17.
Keller S, Williams D, Gavgani M, Hirsch D, Adamovich J, Hohl D
. Rates of and Risk Factors for Adverse Drug Events in Outpatient Parenteral Antimicrobial Therapy. Clin Infect Dis. 2017; 66(1):11-19.
PMC: 5848264.
DOI: 10.1093/cid/cix733.
View
18.
Laupland K, Lyytikainen O, Sogaard M, Kennedy K, Knudsen J, Ostergaard C
. The changing epidemiology of Staphylococcus aureus bloodstream infection: a multinational population-based surveillance study. Clin Microbiol Infect. 2012; 19(5):465-71.
DOI: 10.1111/j.1469-0691.2012.03903.x.
View
19.
Lee B, Seol H, Kim T, Seong E, Song S, Lee D
. Recent clinical overview of renal and perirenal abscesses in 56 consecutive cases. Korean J Intern Med. 2008; 23(3):140-8.
PMC: 2686968.
DOI: 10.3904/kjim.2008.23.3.140.
View
20.
Lenz R, Leal J, Church D, Gregson D, Ross T, Laupland K
. The distinct category of healthcare associated bloodstream infections. BMC Infect Dis. 2012; 12:85.
PMC: 3364909.
DOI: 10.1186/1471-2334-12-85.
View